Home

Genesis Molecular AI Appoints Sergey Edunov as Senior Vice President of Foundation Models, Further Strengthening Leadership in Machine Learning

via Business Wire
  • Former Meta Superintelligence Senior Director brings over 20 years of software engineering, research, and engineering leadership to scale Genesis’ AI platform
  • Appointment of key Llama and FAIR leader reinforces Genesis’ leadership in molecular AI as company showcases new research at NeurIPS 2025

Genesis Molecular AI, the company pioneering the world’s leading AI models for drug design and development, today announced the appointment of Sergey Edunov as Senior Vice President of Foundation Models.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202150934/en/

Sergey Edunov, Senior Vice President of Foundation Models at Genesis Molecular AI

Sergey Edunov, Senior Vice President of Foundation Models at Genesis Molecular AI

Edunov joins Genesis with more than 20 years of experience in research and engineering leadership across the AI and technology sectors, which includes the development of widely adopted machine translation models and infrastructure. He most recently served as Senior Director of AI Research in Meta’s generative AI organization, where he led development of the Llama large language models (LLMs), including the next-generation Llama 2 and Llama 3 systems. Prior to that, he was a research leader on Meta’s Fundamental AI Research (FAIR) team, overseeing large-scale machine translation initiatives. Earlier in his career, Edunov focused on distributed infrastructure for graph algorithms for Apache Giraph, which supported growth and engagement at Facebook. He has also held software engineering roles across several industries.

“Sergey’s contributions to large-scale generative AI research and his experience scaling state-of-the-art models adopted across the tech industry are invaluable as Genesis enters its next chapter of growth,” said Evan Feinberg, Ph.D., founder and CEO of Genesis Molecular AI. “His expertise will be critical as we scale our GEMS platform to design and advance breakthrough medicines.”

“Foundation models are transforming how we approach molecular design, and Sergey's leadership will accelerate our ability to take on the most challenging targets in drug discovery,” said Aleksandra Faust, Ph.D., Chief AI Officer of Genesis Molecular AI. “His experience at Meta delivering both research innovation and real-world impact will help us unlock a new era of AI-driven drug design and development.”

Edunov earned a Master of Science in Applied Physics and Mathematics from Moscow Institute of Physics and Technology. He has co-authored more than 20 publications, with research appearing in high-impact journals including Nature and the Journal of Machine Learning Research, and presented at conferences such as Empirical Methods in Natural Language Processing (EMNLP).

“I believe drug discovery is one of the most consequential applications of AI and offers enormous potential for patient impact,” said Edunov. "I’m thrilled to join Genesis’ exceptional team and help scale its platform to accelerate the discovery of new treatments for previously undruggable diseases.”

About Genesis Molecular AI

Genesis Molecular AI, Inc. (formerly Genesis Therapeutics) is pioneering foundation models for molecular AI to unlock a new era of drug design and development. The company’s generative and predictive AI platform, GEMS (Genesis Exploration of Molecular Space), integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl for structure prediction. Genesis has raised over $300 million from leading AI, tech and life science-focused investors, signed multiple AI-focused research collaborations with major pharma partners, and is deploying GEMS to advance an internal therapeutics pipeline for a variety of high-impact targets.

Genesis is headquartered in the San Francisco Bay Area, with locations in San Diego and New York. Learn more at genesis.ml or follow us on LinkedIn.

Contacts